249 related articles for article (PubMed ID: 21520180)
21. Integration-deficient lentiviral vectors expressing codon-optimized R338L human FIX restore normal hemostasis in Hemophilia B mice.
Suwanmanee T; Hu G; Gui T; Bartholomae CC; Kutschera I; von Kalle C; Schmidt M; Monahan PE; Kafri T
Mol Ther; 2014 Mar; 22(3):567-574. PubMed ID: 23941813
[TBL] [Abstract][Full Text] [Related]
22. Integrase defective, nonintegrating lentiviral vectors.
Michelini Z; Negri D; Cara A
Methods Mol Biol; 2010; 614():101-10. PubMed ID: 20225038
[TBL] [Abstract][Full Text] [Related]
23. Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) mice.
Chen Y; Schroeder JA; Kuether EL; Zhang G; Shi Q
Mol Ther; 2014 Jan; 22(1):169-77. PubMed ID: 24042561
[TBL] [Abstract][Full Text] [Related]
24. Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza.
Michelini Z; Minkoff JM; Yang J; Negri D; Cara A; Hanson BJ; Salvatore M
Viruses; 2020 Dec; 12(12):. PubMed ID: 33348840
[TBL] [Abstract][Full Text] [Related]
25. Non-integrating lentiviral vectors.
Sarkis C; Philippe S; Mallet J; Serguera C
Curr Gene Ther; 2008 Dec; 8(6):430-7. PubMed ID: 19075626
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization.
Bona R; Michelini Z; Mazzei C; Gallinaro A; Canitano A; Borghi M; Vescio MF; Di Virgilio A; Pirillo MF; Klotman ME; Negri D; Cara A
Mol Ther Methods Clin Dev; 2021 Dec; 23():263-275. PubMed ID: 34729374
[TBL] [Abstract][Full Text] [Related]
27. Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein.
Grasso F; Negri DR; Mochi S; Rossi A; Cesolini A; Giovannelli A; Chiantore MV; Leone P; Giorgi C; Cara A
Int J Cancer; 2013 Jan; 132(2):335-44. PubMed ID: 22700466
[TBL] [Abstract][Full Text] [Related]
28. Transduction of human antigen-presenting cells with integrase-defective lentiviral vector enables functional expansion of primed antigen-specific CD8(+) T cells.
Negri DR; Bona R; Michelini Z; Leone P; Macchia I; Klotman ME; Salvatore M; Cara A
Hum Gene Ther; 2010 Aug; 21(8):1029-35. PubMed ID: 20210625
[TBL] [Abstract][Full Text] [Related]
29. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
[TBL] [Abstract][Full Text] [Related]
30. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery.
Lombardo A; Genovese P; Beausejour CM; Colleoni S; Lee YL; Kim KA; Ando D; Urnov FD; Galli C; Gregory PD; Holmes MC; Naldini L
Nat Biotechnol; 2007 Nov; 25(11):1298-306. PubMed ID: 17965707
[TBL] [Abstract][Full Text] [Related]
31. Hybrid lentivirus-transposon vectors with a random integration profile in human cells.
Staunstrup NH; Moldt B; Mátés L; Villesen P; Jakobsen M; Ivics Z; Izsvák Z; Mikkelsen JG
Mol Ther; 2009 Jul; 17(7):1205-14. PubMed ID: 19240688
[TBL] [Abstract][Full Text] [Related]
32. Placenta-specific gene activation and inactivation using integrase-defective lentiviral vectors with the Cre/LoxP system.
Morioka Y; Isotani A; Oshima RG; Okabe M; Ikawa M
Genesis; 2009 Dec; 47(12):793-8. PubMed ID: 19830817
[TBL] [Abstract][Full Text] [Related]
33. Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines.
Negri DR; Rossi A; Blasi M; Michelini Z; Leone P; Chiantore MV; Baroncelli S; Perretta G; Cimarelli A; Klotman ME; Cara A
Retrovirology; 2012 Aug; 9():69. PubMed ID: 22913641
[TBL] [Abstract][Full Text] [Related]
34. Integrase-defective lentiviral vectors: progress and applications.
Banasik MB; McCray PB
Gene Ther; 2010 Feb; 17(2):150-7. PubMed ID: 19847206
[TBL] [Abstract][Full Text] [Related]
35. Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.
Lu-Nguyen NB; Broadstock M; Schliesser MG; Bartholomae CC; von Kalle C; Schmidt M; Yáñez-Muñoz RJ
Hum Gene Ther; 2014 Jul; 25(7):631-41. PubMed ID: 24635742
[TBL] [Abstract][Full Text] [Related]
36. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors.
Wang X; Wang Y; Wu X; Wang J; Wang Y; Qiu Z; Chang T; Huang H; Lin RJ; Yee JK
Nat Biotechnol; 2015 Feb; 33(2):175-8. PubMed ID: 25599175
[TBL] [Abstract][Full Text] [Related]
37. Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice.
Annoni A; Cantore A; Della Valle P; Goudy K; Akbarpour M; Russo F; Bartolaccini S; D'Angelo A; Roncarolo MG; Naldini L
EMBO Mol Med; 2013 Nov; 5(11):1684-97. PubMed ID: 24106222
[TBL] [Abstract][Full Text] [Related]
38. In vivo enrichment of genetically manipulated platelets for murine hemophilia B gene therapy.
Chen Y; Schroeder JA; Gao C; Li J; Hu J; Shi Q
J Cell Physiol; 2021 Jan; 236(1):354-365. PubMed ID: 32510630
[TBL] [Abstract][Full Text] [Related]
39. Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase.
Moldt B; Staunstrup NH; Jakobsen M; Yáñez-Muñoz RJ; Mikkelsen JG
BMC Biotechnol; 2008 Aug; 8():60. PubMed ID: 18691430
[TBL] [Abstract][Full Text] [Related]
40. Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.
Daenthanasanmak A; Salguero G; Borchers S; Figueiredo C; Jacobs R; Sundarasetty BS; Schneider A; Schambach A; Eiz-Vesper B; Blasczyk R; Weissinger EM; Ganser A; Stripecke R
Vaccine; 2012 Jul; 30(34):5118-31. PubMed ID: 22691433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
